This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks / Marchesi, A; Tarissi de Jacobis, I; Rigante, D; Rimini, A; Malorni, W; Corsello, G; Bossi, G; Buonuomo, S; Cardinale, F; Cortis, E; De Benedetti, F; De Zorzi, A; Duse, M; Del Principe, D; Dellepiane, Rm; D'Isanto, L; El Hachem, M; Esposito, S; Falcini, F; Giordano, U; Maggio, Mc; Mannarino, S; Marseglia, G; Martino, S; Marucci, G; Massaro, R; Pescosolido, C; Pietraforte, D; Pietrogrande, Mc; Salice, P; Secinaro, A; Straface, E; Villani, A.. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - 44:(2018), p. 103. [10.1186/s13052-018-0529-2]

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

Esposito S;
2018-01-01

Abstract

This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks / Marchesi, A; Tarissi de Jacobis, I; Rigante, D; Rimini, A; Malorni, W; Corsello, G; Bossi, G; Buonuomo, S; Cardinale, F; Cortis, E; De Benedetti, F; De Zorzi, A; Duse, M; Del Principe, D; Dellepiane, Rm; D'Isanto, L; El Hachem, M; Esposito, S; Falcini, F; Giordano, U; Maggio, Mc; Mannarino, S; Marseglia, G; Martino, S; Marucci, G; Massaro, R; Pescosolido, C; Pietraforte, D; Pietrogrande, Mc; Salice, P; Secinaro, A; Straface, E; Villani, A.. - In: THE ITALIAN JOURNAL OF PEDIATRICS. - ISSN 1824-7288. - 44:(2018), p. 103. [10.1186/s13052-018-0529-2]
File in questo prodotto:
File Dimensione Formato  
Kawasaki disease_guidelines of the Italian Society of Pediatrics - part 2.pdf

accesso aperto

Tipologia: Versione (PDF) editoriale
Licenza: Creative commons
Dimensione 1.31 MB
Formato Adobe PDF
1.31 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2864221
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 25
social impact